ConCallIQ
Go Pro
GO
GODREJAGROVET Other 15 May 2026

Godrej Agrovet Ltd — Q4 FY26

Godrej Agrovet delivered a strong Q4 FY26 with consolidated revenue of ₹2,333 crore (+9% YoY) and PBT growth of 16.8% to ₹87 crore.

bullish high
Revenue ₹2,333 Cr +9%
EBITDA
PAT ₹102 Cr
EBITDA Margin
Duration 65 min

✓ Verified against BSE filing

2-Min Summary

Godrej Agrovet delivered a strong Q4 FY26 with consolidated revenue of ₹2,333 crore (+9% YoY) and PBT growth of 16.8% to ₹87 crore. Full-year revenue crossed ₹10,000 crore milestone at ₹10,233 crore (+9% YoY), with PBT up 17.2% to ₹569 crore. Performance was driven by volume-led growth in animal nutrition (cattle feed volumes +24%), record oil palm area expansion and extraction ratio improvement, and Aztec Life Sciences turning EBITDA positive. Management guided for early double-digit revenue growth and mid-teens PBT growth in FY27, with capex of ~₹350-400 crore and free cash flow of ₹100-125 crore. Key risks include potential El Niño impact on monsoons and Iran war uncertainty affecting palm oil prices and crop protection demand.

Key Numbers

Cattle feed volume growth 24%
+24% YoY

Cattle feed volumes increased sharply by 24% in Q4, significantly ahead of industry growth.

Oil extraction ratio (Q4) 20.77%
+101 bps YoY

Oil extraction ratio improved to 20.77% in Q4 from 19.76% last year, indicating better productivity.

Aztec CDMO revenue share 52%
flat YoY

CDMO contributed 52% of Aztec revenue in FY26; enterprise 48%. Mix expected similar for next two years.

Branded revenue salience (Godrej Foods) 80%+
+2pp YoY

Branded revenue salience remained above 80% in FY26, up from 78% last year, driven by strategic shift.

Management Guidance

G

Early double-digit revenue growth in FY27

Management targets early double-digit consolidated revenue growth for FY27, driven by volume growth across segments.

revenue
G

Mid-teens PBT growth in FY27

Targeting mid-strong double-digit (mid-teens) PBT growth for FY27, building on FY26's 17.2% growth.

growth
G

Capex of ~₹350-400 crore in FY27

Capex expected around ₹350-400 crore, with 75-80% growth capex, ~50% allocated to oil palm.

capex
G

Free cash flow of ₹100-125 crore in FY27

After capex, company expects free cash flow surplus of ₹100-125 crore in FY27.

other

Key Risks

R

El Niño impact on monsoons

Below-normal monsoon predictions could affect crop protection and animal feed demand, though management believes impact may be mitigated by geographic skew and demographic dividend in oil palm.

medium · analyst_question
R

Iran war and palm oil price volatility

The Iran war creates uncertainty in palm oil prices due to correlation with crude oil; management is taking a quarter-by-quarter view.

medium · management_commentary
R

Aztec China raw material dependency

Aztec sourced 47% of imports from China; currency depreciation and supply chain disruptions pose risks, though net exporter status provides a natural hedge.

medium · analyst_question
R

Crop care business recovery delay

Crop care business recovery may be delayed due to carry-forward inventory; full recovery expected only from Q2 FY27.

low · management_commentary

Notable Quotes

We'd like to focus on getting an early double-digit revenue growth across put together at a console level along with the way our PBD has improved this year would like to again target a mid strong double digit mid-teens kind of a PBT growth also for the next year.
Sunil Kataria · CEO and Managing Director
If the Middle East war continues it will probably be bad for the crop protection business but good for oil palm. So for agrovet overall the impact either way may not be very great.
Nadir Godrej · Chairman
We are in the process of evaluating what is the most optimal structures and how it will go forward... the interest of all minority shareholders will be protected and our endeavor is actually to make sure that we enhance shareholder value for everyone.
Burges Godrej · Chairman Designate